Tarsus Pharmaceuticals, Inc. TARS Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s common stock, shares, outstanding?
- Tarsus Pharmaceuticals, Inc. (TARS) reported common stock, shares, outstanding of $43.02M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s common stock, shares, outstanding changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s common stock, shares, outstanding increased by 2.4% year-over-year, from $42M to $43.02M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s common stock, shares, outstanding has grown at a 15.9% compound annual growth rate (CAGR), from $20.32M to $42.55M.